[1]
Inan El-Naggar, A. et al. 2025. Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based study. Acta Oncologica. 64, (Oct. 2025), 1334–1341. DOI:https://doi.org/10.2340/1651-226X.2025.43990.